Docetaxel and ovarian cancer

Author： Cottu Paul H   Mignot Laurent   Diéras Véronique  

Publisher： Informa Healthcare

ISSN： 1747-4108

Source： Expert Review of Obstretrics and Gynecology, Vol.2, Iss.6, 2007-11, pp. : 719-724

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatinum and docetaxel for ovarian cancer in pregnancy

By Rouzi Abdulrahim   Sahly Nora   Sahly Naif   Alahwal Mahmoud  

Archives of Gynecology and Obstetrics, Vol. 280, Iss. 5, 2009-11 ,pp. : 823-825

Springer Publishing Company

Access to resources Recommend Favorite

Topotecan in the treatment of ovarian cancer

By Obel Jennifer   Fleming Gini  

Expert Review of Obstretrics and Gynecology, Vol. 1, Iss. 2, 2006-11 ,pp. : 149-158

Informa Healthcare

Access to resources Recommend Favorite

Is there a place for screening in ovarian cancer?

By MacDonald N.D.   Jacobs I.J.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 82, Iss. 2, 1999-02 ,pp. : 155-157

Elsevier

Access to resources Recommend Favorite

Early detection of ovarian cancer

By Diaz Elena   Burky Robert E   Hummel Charles S   Farias-Eisner Robin  

Expert Review of Obstretrics and Gynecology, Vol. 8, Iss. 2, 2013-03 ,pp. : 169-179

Informa Healthcare

Access to resources Recommend Favorite

An atypical presentation of ovarian cancer

By Moustafa M.   Beynon W. B. G.  

Journal of Obstetrics & Gynaecology, Vol. 22, Iss. 4, 2002-07 ,pp. : 455-456

Informa Healthcare

Access to resources Recommend Favorite